Navigation Links
Gallo Research Center announces new round of awards for $20m US Army-funded research program
Date:10/19/2013

The UCSF-affiliated Ernest Gallo Clinic and Research Center has issued a second round of grants under its U.S. Army-funded research program intended to accelerate the discovery and development of new medications to treat alcohol and substance abuse in the context of post-traumatic stress and combat injury.

The program, known as the Institute for Molecular Neuroscience (IMN), relies on the expertise of a team of national experts who are unaffiliated with grant applicants to conduct an independent peer-review process.

The second round of pilot research grants will support a broad range of projects to investigate potential new treatments for substance abuse, traumatic brain injury and post-traumatic stress. The total funding for this round of awards is $1.25 million. Together with the $3.7 million awarded in round one, the IMN has to date awarded approximately $5 million in proof-of-principle grants.

The IMN Program represents an important new strategy for combating substance abuse and related post-traumatic stress or other combat injuries, said John A. De Luca, PhD, chairman of the board and president of the Gallo Center. These medical conditions are national security health issues. The IMN seeks to address these problems through its multidisciplinary, competitive national research program.

Grant recipients in this round of funding are:

Michael E. Charness

Boston VA Research Institute (Harvard)

$300,000

Lori A. Knackstedt

University of Florida

$306,207

Kenneth M. Lattall

Oregon Health and Science University

$370,881

Eric P. Zorilla

The Scripps Research Institute

$273,088

It is gratifying that Congress and the Defense Department have embraced the IMN Program and its new approach to accelerating the discovery of new medications to address substance abuse, post-traumatic stress and other conditions facing our military personnel and veterans, said William R. Sawyers, chief administrative officer of the IMN and the Gallo Center.

The UCSF-affiliated Gallo Research Center was selected to manage the IMN Program in recognition of its expertise in the neurobiology of addiction and in managing large research projects. The strategy of the IMN, which funds short-term pilot projects, and then selects only the most compelling for advancement, represents a new approach to the development of medications for the U.S. Military.

The IMN Program is comprised of a consortium of 18 leading research universities and research institutions across the country. Institutions which have received IMN funding previously include Columbia University, Oregon Health and Science University, the Medical University of South Carolina, Yale University, the University of Texas, Austin, the Northern California Institute for Research and Education (NCIRE) and UCSF.

Congressional appropriations for the IMN Program to date total $20.1 million, said De Luca. Later this year, the IMN will select the most promising of its first round of pilot projects to be advanced into the next stage of medications development, said Sawyers.


'/>"/>

Contact: Peter Farley
peter.farley@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert  

Related medicine news :

1. Gallo Research Center to lead $15 million US Army-funded national research program
2. Increasing dopamine in frontal cortex decreases impulsive tendency, UCSF-Gallo scientists find
3. Increasing dopamine in brains frontal cortex decreases impulsive tendency, UCSF-Gallo study finds
4. Does gallows humor among physicians encourage accusations of murder and euthanasia?
5. A Milestone: Pool Services Technologies Just Conserved 7.5 Million Gallons of Water in San Diego
6. Gallo Center study in mice links cocaine use to new brain structures
7. Automotive Paints Market Worth 998.7 Million Gallons by 2018 with Revenue of $11.7 Billion - New Report by MarketsandMarkets
8. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
9. NIH awards $20 million over 5 years to train next generation of global health researchers
10. Researchers develop a new cell and animal model of inflammatory breast cancer
11. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gallo Research Center announces new round of awards for $20m US Army-funded research program
(Date:4/29/2016)... Francisco, CA (PRWEB) , ... April 29, 2016 ... ... released fertility clinic data for 2014. Each year, reproductive endocrinologists are required to ... and SART, the main organization of professionals dedicated to the practice of assisted ...
(Date:4/29/2016)... ... April 29, 2016 , ... In its efforts of ... Services continues its successful franchise development and expansion as it welcomes Ferdie Vasquez of ... and administrative experience in his 32 years of working in various industries. He ...
(Date:4/28/2016)... ... 28, 2016 , ... The Dentists Insurance Company ... a letter of intent with Moda to acquire Dentists Benefits Insurance ... Started by dentists 36 years ago, TDIC focuses exclusively on supporting the dental ...
(Date:4/28/2016)... ... April 28, 2016 , ... CastCoverz!, America’s #1 trusted brand ... country's oldest waterproof cast protector . As the largest one-stop, orthopedic shop, ... of daily, night, weatherproof and waterproof covers for most orthopedic devices, including but ...
(Date:4/28/2016)... ... April 28, 2016 , ... The ARRS 2016 ... medical professionals from around the globe who attended a week’s worth of cutting-edge ... April 17 included the introduction of the 2016 ARRS Distinguished Educator, Dr. Gerald ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016   Acsis , a ... that leading IT market research and advisory firm IDC ... the IDC MarketScape: Worldwide Pharmaceutical Track and Trace Software ... report provides an assessment of the capabilities and business ... trace software market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/28/2016)... , April 28, 2016 TapImmune,Inc. ... of innovative peptide and gene-based immunotherapeutics and vaccines for the ... be presenting at the 3rd Annual Growth Capital Expo ... th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... on Wednesday, May 4 th by Dr. John ...
(Date:4/27/2016)... April 27, 2016  Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended March ... of $0.24 increased 41.2%, and non-GAAP diluted EPS ... increased 5.8% on a reported basis, and 6.3% ... "We posted another good quarter, highlighted by 14.6% ...
Breaking Medicine Technology: